Rinri Therapeutics at Cell 2026

Nov 12–13, 2026 London, UK ~800 attendees Website

Rinri Therapeutics takes part in 3 sessions at Cell 2026 in London. Its program centres on restoring hearing with cell and gene therapies and on closing the gap between lab models and medicines. It traces a regenerative cell therapy for hearing loss from the lab to patients.

Organization	Cell 2026 Attendance
Rinri Therapeutics Sheffield, UK
rinri-therapeutics.com Biotech Clinical-stage company developing regenerative cell therapies for sensorineural hearing loss.	Talk Thu Nov 12 4:55pm–5:20pm Featured Session: Restoring Hearing With Cell & Gene Therapies: From Bench To Bedside - Developing A World-First Regenerative Cell Therapy For Hearing Loss Cell and gene therapy Panel Thu Nov 12 5:45pm–6:10pm Featured Session: Restoring Hearing With Cell & Gene Therapies: From Bench To Bedside with University of Cambridge, Sensorion Cell and gene therapy Panel Fri Nov 13 11:40am–12:05pm From Model To Medicine: Fixing The Translation Gap with ValiRx, a:head bio, MeiraGTx Stem cells, organoids and cell models

Organization

Cell 2026 Attendance

Rinri Therapeutics

Sheffield, UK

rinri-therapeutics.com

Biotech

Clinical-stage company developing regenerative cell therapies for sensorineural hearing loss.

Talk

Thu Nov 12
4:55pm–5:20pm

Featured Session: Restoring Hearing With Cell & Gene Therapies: From Bench To Bedside - Developing A World-First Regenerative Cell Therapy For Hearing Loss

Cell and gene therapy

Panel